CNVVF
Price
$3.00
Change
-$0.08 (-2.60%)
Updated
Mar 26 closing price
Capitalization
5.48B
EW
Price
$76.10
Change
-$0.00 (-0.00%)
Updated
May 22 closing price
Capitalization
57.52B
62 days until earnings call
Interact to see
Advertisement

CNVVF vs EW

Header iconCNVVF vs EW Comparison
Open Charts CNVVF vs EWBanner chart's image
ConvaTec Group
Price$3.00
Change-$0.08 (-2.60%)
Volume$2K
Capitalization5.48B
Edwards Lifesciences
Price$76.10
Change-$0.00 (-0.00%)
Volume$23.99K
Capitalization57.52B
CNVVF vs EW Comparison Chart
Loading...
EW
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CNVVF vs. EW commentary
May 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNVVF is a Hold and EW is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
May 23, 2025
Stock price -- (CNVVF: $3.00 vs. EW: $76.10)
Brand notoriety: CNVVF: Not notable vs. EW: Notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: CNVVF: 82% vs. EW: 1%
Market capitalization -- CNVVF: $5.48B vs. EW: $57.52B
CNVVF [@Medical Specialties] is valued at $5.48B. EW’s [@Medical Specialties] market capitalization is $57.52B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.5B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CNVVF’s FA Score shows that 1 FA rating(s) are green whileEW’s FA Score has 1 green FA rating(s).

  • CNVVF’s FA Score: 1 green, 4 red.
  • EW’s FA Score: 1 green, 4 red.
According to our system of comparison, EW is a better buy in the long-term than CNVVF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EW’s TA Score shows that 6 TA indicator(s) are bullish.

  • EW’s TA Score: 6 bullish, 5 bearish.

Price Growth

CNVVF (@Medical Specialties) experienced а 0.00% price change this week, while EW (@Medical Specialties) price change was -1.01% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.76%. For the same industry, the average monthly price growth was +7.03%, and the average quarterly price growth was +0.10%.

Reported Earning Dates

EW is expected to report earnings on Jul 24, 2025.

Industries' Descriptions

@Medical Specialties (+0.76% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EW($57.5B) has a higher market cap than CNVVF($5.48B). CNVVF has higher P/E ratio than EW: CNVVF (85.47) vs EW (40.98). CNVVF YTD gains are higher at: 3.806 vs. EW (2.796). EW has higher annual earnings (EBITDA): 1.76B vs. CNVVF (356M). EW has more cash in the bank: 1.64B vs. CNVVF (144M). EW has less debt than CNVVF: EW (695M) vs CNVVF (1.3B). EW has higher revenues than CNVVF: EW (6.01B) vs CNVVF (2.07B).
CNVVFEWCNVVF / EW
Capitalization5.48B57.5B10%
EBITDA356M1.76B20%
Gain YTD3.8062.796136%
P/E Ratio85.4740.98209%
Revenue2.07B6.01B35%
Total Cash144M1.64B9%
Total Debt1.3B695M187%
FUNDAMENTALS RATINGS
CNVVF vs EW: Fundamental Ratings
CNVVF
EW
OUTLOOK RATING
1..100
4711
VALUATION
overvalued / fair valued / undervalued
1..100
6
Undervalued
84
Overvalued
PROFIT vs RISK RATING
1..100
6092
SMR RATING
1..100
9520
PRICE GROWTH RATING
1..100
5750
P/E GROWTH RATING
1..100
8873
SEASONALITY SCORE
1..100
n/a23

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CNVVF's Valuation (6) in the null industry is significantly better than the same rating for EW (84) in the Medical Specialties industry. This means that CNVVF’s stock grew significantly faster than EW’s over the last 12 months.

CNVVF's Profit vs Risk Rating (60) in the null industry is in the same range as EW (92) in the Medical Specialties industry. This means that CNVVF’s stock grew similarly to EW’s over the last 12 months.

EW's SMR Rating (20) in the Medical Specialties industry is significantly better than the same rating for CNVVF (95) in the null industry. This means that EW’s stock grew significantly faster than CNVVF’s over the last 12 months.

EW's Price Growth Rating (50) in the Medical Specialties industry is in the same range as CNVVF (57) in the null industry. This means that EW’s stock grew similarly to CNVVF’s over the last 12 months.

EW's P/E Growth Rating (73) in the Medical Specialties industry is in the same range as CNVVF (88) in the null industry. This means that EW’s stock grew similarly to CNVVF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
EW
RSI
ODDS (%)
Bearish Trend 1 day ago
54%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
57%
Momentum
ODDS (%)
Bullish Trend 1 day ago
71%
MACD
ODDS (%)
Bearish Trend 1 day ago
59%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
58%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
62%
Advances
ODDS (%)
Bullish Trend 5 days ago
62%
Declines
ODDS (%)
Bearish Trend 1 day ago
58%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
65%
Aroon
ODDS (%)
Bullish Trend 1 day ago
54%
View a ticker or compare two or three
Interact to see
Advertisement
EW
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
KNGCX11.50N/A
N/A
Vest S&P500 Div Aristocrats Trgt Inc C
FSCCX30.43N/A
N/A
Nuveen Small Cap Value I
PGLRX16.63N/A
N/A
Putnam Focused International Equity R
CSGZX70.99N/A
N/A
Columbia Seligman Global Tech Inst
FBCGX35.51N/A
N/A
Fidelity Blue Chip Growth K6

CNVVF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CNVVF has been loosely correlated with FLMNY. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if CNVVF jumps, then FLMNY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNVVF
1D Price
Change %
CNVVF100%
N/A
FLMNY - CNVVF
36%
Loosely correlated
N/A
SAFLY - CNVVF
32%
Poorly correlated
N/A
GKOS - CNVVF
24%
Poorly correlated
+2.50%
EW - CNVVF
23%
Poorly correlated
N/A
OFIX - CNVVF
22%
Poorly correlated
-2.43%
More